BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12351491)

  • 1. Small bowel motility affects glucose absorption in a healthy man.
    Schwartz MP; Samsom M; Renooij W; van Steenderen LW; Benninga MA; van Geenen EJ; van Herwaarden MA; de Smet MB; Smout AJ
    Diabetes Care; 2002 Oct; 25(10):1857-61. PubMed ID: 12351491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus.
    Rayner CK; Schwartz MP; van Dam PS; Renooij W; de Smet M; Horowitz M; Smout AJ; Samsom M
    Am J Gastroenterol; 2002 Dec; 97(12):3123-30. PubMed ID: 12492199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
    Chaikomin R; Wu KL; Doran S; Jones KL; Smout AJ; Renooij W; Holloway RH; Meyer JH; Horowitz M; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1099-104. PubMed ID: 17204542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
    Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of small intestinal burst activity in the postprandial state differentially affects lipid and glucose absorption in healthy adult humans.
    Bryant LK; Fraser RJ; Vozzo R; Zacharakis B; Matthews GM; Butler R
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1028-34. PubMed ID: 15191881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
    Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced intestinal motility influences absorption in anaesthetized rat.
    Sababi M; Bengtsson UH
    Acta Physiol Scand; 2001 Jun; 172(2):115-22. PubMed ID: 11442451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cisapride on gastric sensitivity to distension, gastric compliance and duodeno-gastric reflexes in healthy humans.
    Manes G; Domínguez-Muñoz JE; Leodolter A; Malfertheiner P
    Dig Liver Dis; 2001; 33(5):407-13. PubMed ID: 11529652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Crouch B; Jones KL; Horowitz M; Rayner CK
    Diabetes; 2016 Jan; 65(1):269-75. PubMed ID: 26470783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility.
    Lux G; Katschinski M; Ludwig S; Lederer P; Ellermann A; Domschke W
    Scand J Gastroenterol; 1994 Dec; 29(12):1105-10. PubMed ID: 7886398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous glucagon-like peptide-1 attenuates glucose absorption and reduces blood glucose concentration after small intestinal glucose delivery in critical illness.
    Miller A; Deane AM; Plummer MP; Cousins CE; Chapple LS; Horowitz M; Chapman MJ
    Crit Care Resusc; 2017 Mar; 19(1):37-42. PubMed ID: 28215130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects.
    Ma J; Chang J; Checklin HL; Young RL; Jones KL; Horowitz M; Rayner CK
    Br J Nutr; 2010 Sep; 104(6):803-6. PubMed ID: 20420761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia.
    Rayner CK; Su YC; Doran SM; Jones KL; Malbert CH; Horowitz M
    Am J Gastroenterol; 2000 Sep; 95(9):2233-41. PubMed ID: 11007223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment by prolonged ambulatory manometry of the effect of oral cisapride on proximal small bowel inter-digestive motility.
    Benson MJ; Castillo FD; Deeks JJ; Wingate DL
    Dig Dis Sci; 1992 Oct; 37(10):1569-75. PubMed ID: 1396005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes.
    Wu T; Xie C; Wu H; Jones KL; Horowitz M; Rayner CK
    Diabetes Obes Metab; 2017 Feb; 19(2):290-293. PubMed ID: 27761984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
    Fraser RJ; Horowitz M; Maddox AF; Dent J
    Gut; 1994 Feb; 35(2):172-8. PubMed ID: 8307466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill.
    Deane AM; Wong GL; Horowitz M; Zaknic AV; Summers MJ; Di Bartolomeo AE; Sim JA; Maddox AF; Bellon MS; Rayner CK; Chapman MJ; Fraser RJ
    Am J Clin Nutr; 2012 Jun; 95(6):1396-402. PubMed ID: 22572649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effects of hypoglycemia on glucose absorption in healthy men.
    Møller J; Laker MF; Gillespie SM; Ovesen PG; Abildgaard N; Tian R; Jørgensen JO; Møller N
    Diabetes Care; 1992 Oct; 15(10):1264-6. PubMed ID: 1425086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cisapride on lower esophageal sphincter pressure and gastroduodenal motor activity in man].
    Nishioka T; Sekiguchi T; Machida M; Kusano M; Kogure M; Matsuzaki T; Katoh R; Horikoshi T; Fukagawa H; Tajima H
    Nihon Heikatsukin Gakkai Zasshi; 1986 Apr; 22(2):103-12. PubMed ID: 3795673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.